Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.7B | 2.5B | 2.5B |
Cost of revenue | 294M | 314M | 286M | 280M |
Gross profit | 2.4B | 2.4B | 2.3B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.6B | 1.6B | 1.5B | 1.5B |
Other operating expenses | — | — | — | — |
Operating income | 434M | 498M | 422M | 365M |
Non operating interest income | ||||
Income | 12M | 9M | 11M | 10M |
Expense | 63M | 63M | 67M | 60M |
Other income expense | -180M | -74M | -98M | -65M |
Pretax income | 227M | 363M | 270M | 252M |
Tax provision | 87M | 44M | 83M | 65M |
Net income | 140M | 319M | 187M | 187M |
Basic EPS | 5.4 | — | 7.7 | 8.4 |
Diluted EPS | 5.4 | — | 7.7 | 8.4 |
Basic average shares | 21.2M | — | 21.2M | 21.2M |
Diluted average shares | 21.2M | — | 21.2M | 21.2M |
EBITDA | 641M | 711M | 685M | 621M |
Net income from continuing op. | 140M | 319M | 187M | 187M |
Minority interests | -24M | -35M | -23M | -10M |
Preferred stock dividends | — | — | — | — |